Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00774228 · ClinicalTrials.gov registry record · NA

I-ZIP Ocular Bandage Pivotal Study

A NA study of Cataract, sponsored by Ocular Therapeutix.

Completed
Registry status
NA
Development phase
420
Enrollment target
1
Study location

NCT00774228: Completed NA study of Cataract, sponsored by Ocular Therapeutix.

NCT00774228 is a NA study of Cataract that has completed, run by Ocular Therapeutix. The registered enrollment target is 420 participants, above the 223-participant average among 83 other Cataract trials with a reported enrollment target (88% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00774228, a NA study of Cataract, has completed, sponsored by Ocular Therapeutix.

COMPLETED
Registry status
NA
Development phase
420 participants
Enrollment target
1
Study location

Study Summary

To evaluate the safety and performance of the I-ZIP Ocular Bandage in subjects undergoing uneventful unilateral clear corneal phacoemulsification with foldable monofocal intraocular lens (IOL) implantation compared with the Oasis 24-hour Soft Shield Collagen Corneal Shield (Oasis Medical, Inc. Glendora, California) for providing ocular protection and relief of pain or discomfort in the acute post-operative period.

Conditions Studied

Interventions

  • DEVICE I-ZIP Ocular Bandage
  • DEVICE Oasis 24 Hour Soft Shield Collagen Corneal Shield

Study Locations (1)

Massachusetts

  • I-Therapeutix, Inc. - Waltham

Trial Details

FieldValue
Enrollment Target 420 participants
Start Date 2008-10
Est. Completion 2009-08
Phase NA
Ocular Therapeutix

20 total trials

What the finished NCT00774228 record still lists

NCT00774228 is an interventional study that assigns participants to a tested intervention. The registered 420 participants enrollment target is mid-sized for trials with a published cap, above the 223-participant average among 83 other Cataract trials with a reported enrollment target (88% higher).

The record links to 1 condition, with Cataract appearing as the primary indexed condition, and to 2 interventions - of which I-ZIP Ocular Bandage is the first listed.

NCT00774228 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT00774228 about?

NCT00774228 is a clinical study titled "I-ZIP Ocular Bandage Pivotal Study". To evaluate the safety and performance of the I-ZIP Ocular Bandage in subjects undergoing uneventful unilateral clear corneal phacoemulsification with foldable monofocal intraocular lens (IOL) implantation compared with the Oasis 24-hour Soft Shield Collagen Corneal Shield (Oasis Medical, Inc. Glend...

What is the current status of trial NCT00774228?

This trial is currently completed. It is a NA study. The enrollment target is 420 participants. The study started on 2008-10. Estimated completion is 2009-08.

What conditions does trial NCT00774228 study?

This clinical trial studies the following conditions: Cataract.

What interventions are being tested in trial NCT00774228?

The interventions under investigation include: I-ZIP Ocular Bandage (DEVICE), Oasis 24 Hour Soft Shield Collagen Corneal Shield (DEVICE).

Who is sponsoring clinical trial NCT00774228?

This trial is sponsored by Ocular Therapeutix, which has 20 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00774228 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cataract

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00774228's enrollment target sits among peer trials

420 9th of 83 higher than 75 of 83 other Cataract trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cataract trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01790152 · 420 participants

    Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

  • NCT02701244 · 420 participants

    A Registry Study of Breast Microseed Treatment

  • NCT02966665 · 420 participants · Phase 1

    : Vascular Function in Health and Disease

  • NCT04149743 · 420 participants · NA

    HEMOTAG® Assessment for Short-term Outcomes of Heart Failure

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00774228, the US trial registry maintained by the National Library of Medicine. NCT00774228 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.